Boston Scientific Corp (BSX)vsFomento Economico Mexicano (FMX)
BSX
Boston Scientific Corp
$69.78
+2.39%
HEALTHCARE · Cap: $101.28B
FMX
Fomento Economico Mexicano
$108.51
+2.56%
CONSUMER DEFENSIVE · Cap: $36.56B
Smart Verdict
WallStSmart Research — data-driven comparison
Fomento Economico Mexicano generates 4089% more annual revenue ($840.95B vs $20.07B). BSX leads profitability with a 14.4% profit margin vs 2.3%. BSX appears more attractively valued with a PEG of 0.75. BSX earns a higher WallStSmart Score of 63/100 (C+).
BSX
Buy63
out of 100
Grade: C+
FMX
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.2%
Fair Value
$70.62
Current Price
$69.78
$0.84 discount
Margin of Safety
+15.9%
Fair Value
$134.78
Current Price
$108.51
$26.27 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Earnings expanding 63.8% YoY
Generating 9.5B in free cash flow
Areas to Watch
Premium valuation, high expectations priced in
Premium valuation, high expectations priced in
2.3% margin — thin
Weak financial health signals
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : FMX
The strongest argument for FMX centers on EPS Growth, Free Cash Flow.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : FMX
The primary concerns for FMX are P/E Ratio, Profit Margin, Piotroski F-Score. Thin 2.3% margins leave little buffer for downturns.
Key Dynamics to Monitor
BSX profiles as a growth stock while FMX is a value play — different risk/reward profiles.
BSX carries more volatility with a beta of 0.70 — expect wider price swings.
BSX is growing revenue faster at 15.9% — sustainability is the question.
FMX generates stronger free cash flow (9.5B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (63/100 vs 59/100) and 15.9% revenue growth. FMX offers better value entry with a 15.9% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Fomento Economico Mexicano
CONSUMER DEFENSIVE · BEVERAGES - BREWERS · USA
Fomento Econmico Mexicano, SAB de CV, is a bottler of Coca-Cola brand beverages. The company is headquartered in Monterrey, Mexico.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?